Galcanezumab effect on “whole pain burden” and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Galcanezumab effect on “whole pain burden” and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience
Authors
Keywords
-
Journal
JOURNAL OF HEADACHE AND PAIN
Volume 23, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-06-14
DOI
10.1186/s10194-022-01436-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score
- (2022) Luigi Francesco Iannone et al. CNS DRUGS
- Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis
- (2021) Patricia Pozo-Rosich et al. ADVANCES IN THERAPY
- Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
- (2021) Fabrizio Vernieri et al. JOURNAL OF HEADACHE AND PAIN
- Refractory migraine profile in CGRP‐monoclonal antibodies scenario
- (2021) Marcello Silvestro et al. ACTA NEUROLOGICA SCANDINAVICA
- Are PROMs passing the message? A reflection with real-life migraine patients
- (2021) Raquel Gil-Gouveia et al. CEPHALALGIA
- Chronic versus episodic migraine: The 15‐day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency
- (2021) Ryotaro Ishii et al. HEADACHE
- Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months
- (2021) Edoardo Caronna et al. JOURNAL OF HEADACHE AND PAIN
- Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study
- (2021) Sara Bottiroli et al. JOURNAL OF HEADACHE AND PAIN
- CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs
- (2021) Fenne Vandervorst et al. JOURNAL OF HEADACHE AND PAIN
- Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience
- (2020) Antonio Russo et al. JOURNAL OF HEADACHE AND PAIN
- Impact of galcanezumab on total pain burden: findings from phase 3 randomized, double-blind, placebo-controlled studies in patients with episodic or chronic migraine (EVOLVE-1, EVOLVE-2, and REGAIN trials)
- (2020) Jessica Ailani et al. JOURNAL OF HEADACHE AND PAIN
- Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial
- (2020) Wim M Mulleners et al. LANCET NEUROLOGY
- Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019
- (2020) T. J. Steiner et al. JOURNAL OF HEADACHE AND PAIN
- European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
- (2019) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Therapeutic novelties in migraine: new drugs, new hope?
- (2019) Thien Phu Do et al. JOURNAL OF HEADACHE AND PAIN
- Preventive Treatment for Episodic Migraine
- (2019) Simy K. Parikh et al. NEUROLOGIC CLINICS
- Migraine progression in subgroups of migraine based on comorbidities
- (2019) Richard B. Lipton et al. NEUROLOGY
- Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
- (2018) Vladimir Skljarevski et al. CEPHALALGIA
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Evaluation of Galcanezumab for the Prevention of Episodic Migraine
- (2018) Virginia L. Stauffer et al. JAMA Neurology
- Galcanezumab in chronic migraine
- (2018) Holland C. Detke et al. NEUROLOGY
- The Association between Migraine and Types of Sleep Disorder
- (2018) Seung Kim et al. International Journal of Environmental Research and Public Health
- Headache, depression and anxiety: associations in the Eurolight project
- (2016) Christian Lampl et al. JOURNAL OF HEADACHE AND PAIN
- Migraine diagnosis and treatment: A knowledge and needs assessment among primary care providers
- (2015) Mia T Minen et al. CEPHALALGIA
- Drug safety and tolerability in prophylactic migraine treatment
- (2015) László Vécsei et al. Expert Opinion On Drug Safety
- Symptom dimensions of affective disorders in migraine patients
- (2015) M.A. Louter et al. JOURNAL OF PSYCHOSOMATIC RESEARCH
- CGRP and VIP Levels as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine
- (2014) Eva Cernuda-Morollón et al. HEADACHE
- Cutaneous allodynia as a predictor of migraine chronification
- (2013) Mark A. Louter et al. BRAIN
- Depression and risk of transformation of episodic to chronic migraine
- (2012) Sait Ashina et al. JOURNAL OF HEADACHE AND PAIN
- Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Table 1
- (2012) S.D. Silberstein et al. NEUROLOGY
- Increased Prevalence of Sleep Disorders in Chronic Headache: A Case-Control Study
- (2010) Elisa Sancisi et al. HEADACHE
- Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers
- (2010) D C Buse et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Current practice and future directions in the prevention and acute management of migraine
- (2010) Peter J Goadsby et al. LANCET NEUROLOGY
- Underdiagnosis and Undertreatment of Migraine in Italy: A Survey of Patients Attending for The First Time 10 Headache Centres
- (2009) S Cevoli et al. CEPHALALGIA
- Psychometric evaluation and tests of validity of the Medical Outcomes Study 12-item Sleep Scale (MOS sleep)
- (2008) Richard P. Allen et al. SLEEP MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started